Barry D Quart Kiniksa Pharmaceuticals, Ltd. (KNSA) insider trading activity

Barry D Quart is of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 12,546 shares of KNSA, which is worth approximately $357,435. The most recent transaction as insider was on Jun 11, 2025, when has been sold 12,336 shares (Class A Ordinary Share) at a price of $30.39 per share, resulting in proceeds of $374,891. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.5K

33.85% 3M change

33.85% 12M change

Total Value Held $357,435

Barry D Quart Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 11 2025	SELL Open market or private sale	$374,891 $30.39 p/Share	12,336 Reduced 49.58%	12,546 Class A Ordinary Share
Jun 11 2025	BUY Exercise of conversion of derivative security	$46,876 $3.8 p/Share	12,336 Added 33.15%	24,882 Class A Ordinary Share
Jun 10 2025	SELL Open market or private sale	$249,316 $30.36 p/Share	8,212 Reduced 39.56%	12,546 Class A Ordinary Share
Jun 10 2025	BUY Exercise of conversion of derivative security	$31,205 $3.8 p/Share	8,212 Added 28.35%	20,758 Class A Ordinary Share
Jun 09 2025	SELL Open market or private sale	$208,794 $30.26 p/Share	6,900 Reduced 35.48%	12,546 Class A Ordinary Share
Jun 09 2025	BUY Exercise of conversion of derivative security	$26,220 $3.8 p/Share	6,900 Added 26.19%	19,446 Class A Ordinary Share
Jun 05 2025	BUY Exercise of conversion of derivative security	-	3,173 Added 20.19%	12,546 Class A Ordinary Share
Jun 06 2024	BUY Exercise of conversion of derivative security	-	4,373 Added 31.81%	9,373 Class A Common Share
Jun 29 2023	BUY Exercise of conversion of derivative security	-	5,000 Added 50.0%	5,000 Class A Common Share
Nov 29 2022	SELL Open market or private sale	$354,637 $16.15 p/Share	21,959 Reduced 100.0%	0 Class A Common Share
Nov 29 2022	BUY Exercise of conversion of derivative security	$34,914 $1.59 p/Share	21,959 Added 50.0%	21,959 Class A Common Share

Also insider at

HRTX

HERON THERAPEUTICS, INC. Healthcare

Chief Executive Officer

BDQ

Barry D Quart

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Value

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Track Activities on KNSA

Account